Physician
Alcera-Poe, Remedios
Alcera-Poe, Remedios was paid $278K by Medicaid between Feb 2018 and Dec 2024, across 40 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 50% of everything it billed.
33Billing provider infoALCERA-POE, REMEDIOS
MILWAUKEE, WI 53215
MILWAUKEE, WI 53215
33aNPI1891799284assigned 06/13/2005
33bProvider typePediatrics Physician
28Total paid$278K
24GClaims10,639
24DCodes billed40
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Wisconsin
Rank by total paid#31 of 200
Median peer was paid$4K
This provider vs. median64×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 621 | $14K | |
| 2019 | 159 | $5K | |
| 2023 | 1,325 | $23K | |
| 2024incomplete | 8,534 | $236K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 50% | 2,365 | 2,068 | $139K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.8% | 315 | 289 | $19K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.1% | 281 | 257 | $17K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.6% | 178 | 168 | $13K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.3% | 408 | 359 | $12K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.2% | 578 | 382 | $12K |
| 99173 | 3.4% | 576 | 533 | $10K | |
| 92551 | 3.0% | 645 | 596 | $8K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.9% | 577 | 516 | $8K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.3% | 99 | 83 | $6K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.1% | 101 | 88 | $6K |
| 90686 | 1.7% | 402 | 376 | $5K |
28 more codes
| 3008F | 1.7% | 834 | $5K | |
| 87807 | 1.1% | 290 | $3K | |
| 96127 | 1.0% | 566 | $3K | |
| 99188 | <1% | 226 | $2K | |
| 99000 | <1% | 369 | $1K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 95 | $1K |
| 83655 | <1% | 90 | $992.85 | |
| 90651 | <1% | 79 | $983.70 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 14 | $807.31 |
| 90619 | <1% | 49 | $735.60 | |
| 90716 | <1% | 53 | $708.31 | |
| 90707 | <1% | 51 | $696.66 | |
| 90633 | <1% | 30 | $450.00 | |
| 90677 | <1% | 28 | $430.80 | |
| 36416 | <1% | 182 | $375.09 | |
| 90674 | <1% | 28 | $371.70 | |
| 90715 | <1% | 28 | $360.00 | |
| 90696 | <1% | 26 | $351.66 | |
| 90620 | <1% | 14 | $203.10 | |
| 90647 | <1% | 12 | $180.00 | |
| 80061 | Lipid panel | <1% | 19 | $152.89 |
| 85018 | <1% | 32 | $97.09 | |
| 81002 | <1% | 28 | $83.64 | |
| 88738 | <1% | 12 | $81.96 | |
| 82947 | <1% | 19 | $48.84 | |
| 82948 | <1% | 18 | $31.99 | |
| 90461 | 0% | 273 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 649 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.